ArticleBiomedical optics express2025
Leveraging pretrained vision transformers for automated cancer diagnosis in optical coherence tomography images.
Article in Biomedical optics express, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
This study presents an approach to brain cancer detection based on optical coherence tomography (OCT) images and advanced machine learning techniques. The research addresses the critical need for accurate, real-time differentiation between cancerous and noncancerous brain tissue during neurosurgical procedures. The proposed method combines a pre-trained large vision transformer (ViT) model, specifically DINOv2, with a convolutional neural network (CNN) operating on the grey level co-occurrence matrix (GLCM) texture features. This dual-path architecture leverages both the global contextual feature extraction capabilities of transformers and the local texture analysis strengths of GLCM + CNNs. To mitigate patient-specific bias from the limited cohort, we incorporate an adversarial discriminator network that attempts to identify individual patients from feature representations, creating a competing objective that forces the model to learn generalizable cancer-indicative features rather than patient-specific characteristics. We also explore an alternative state space model approach using MambaVision blocks, which achieves comparable performance. The dataset comprised OCT images from 11 patients, with 5,831 B-frame slices from 7 patients used for training and validation, and 1,610 slices from 4 patients used for testing. The model achieved high accuracy in distinguishing cancerous from noncancerous tissue, with over 99% accuracy on the training dataset, 98.8% on the validation dataset and 98.6% accuracy on the test dataset. This approach demonstrates significant potential for achieving and improving intraoperative decision-making in brain cancer surgeries, offering real-time, high-accuracy tissue classification and surgical guidance.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.